Eyenovia, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
EYEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
295 Madison Avenue,, Suite 2400, New York, NY

Insiders trading volume in the past year

Eyenovia, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stuart M. Grant 10%+ Owner $7.2M +$1.18M +19.5% Jul 2, 2024
Fredric N. Eshelman Director $1.83M Nov 17, 2021
Tsontcho Ianchulev Director $1.54M Jun 12, 2024
Michael Rowe Chief Executive Officer, Director $893K +$51.6K +6.13% Aug 28, 2024
Luke Clauson VP Research & Development $771K Jun 16, 2021
Ernest Mario Director $578K Nov 17, 2021
John P. Gandolfo Chief Financial Officer $421K Feb 12, 2024
Charles E. Mather IV Director $361K Jun 12, 2024
Ellen R. Strahlman Director $334K +$8.1K +2.48% Jun 12, 2024
Bren Kern Chief Operating Officer $304K Feb 12, 2024
Rachel Jacobson Director $290K Jun 12, 2024
Michael Geltzeiler Director $284K Jun 12, 2024
Ram Palanki Director $283K Jun 12, 2024
Kenneth B. Lee Jr Director $273K Jun 16, 2022
Julia A. Haller Director $226K Jun 16, 2022
Stephen Keith Benjamin Director $220K Jun 16, 2022
Jennifer Clasby VP, Regulatory and Clinical $124K Jun 17, 2021
Curt H. LaBelle Director $115K Nov 17, 2021
Anthony Y. Sun Director $93.8K Nov 17, 2021
Andrew D. Jones Chief Financial Officer Aug 30, 2024

Recent Insider Transactions by Companies or Individuals for Eyenovia, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.